As Focus On Sex-Specific Evidence Continues To Grow FDA Women's Health Leader To Open Women's HealthX 2026
“Awareness is no longer the bottleneck in women’s health"
Associate Commissioner for Women’s Health joins leaders from Novartis, Elevance Health, Humana and more this December in Boston
BOSTON, MA, UNITED STATES, September 14, 2026 /EINPresswire.com/ -- Women’s HealthX has announced that Dr. Kaveeta Vasisht, MD, PharmD, Associate Commissioner for Women’s Health and Director of the Office of Women’s Health (OWH) at the U.S. Food and Drug Administration (FDA), will deliver the opening keynote address at its inaugural summit, taking place December 3–4, 2026, at Encore Boston Harbor.
The announcement comes during a transformative shift in regulatory and clinical standards across the women’s health ecosystem. Recent high-profile regulatory milestones—including the FDA’s historic accelerated approval of AstraZeneca’s breast cancer therapy camizestrant guided by ctDNA liquid biopsy biomarkers—underscore the mounting industry demand for sex-differentiated endpoints, earlier intervention models, and representative clinical trials under federal Diversity Action Plan mandates.
Dr. Vasisht’s keynote will address the critical role of sex-specific evidence generation, lifecycle health research, and next-generation clinical trial design in translating scientific innovation into equitable patient access.
Dr. Vasisht will be joined on the program by senior decision-makers from across healthcare financing, delivery, and research, including:
- Payers & Employers: Elevance Health, Humana, CVS Health, Blue Cross Blue Shield of Tennessee
- Biopharma & Life Sciences: Novartis, Organon, EMD Serono
- Health Systems & Providers: Mass General Brigham, WellSpan Health, Corewell Health
Women’s HealthX 2026 convenes cross-sector stakeholders to move beyond siloed point-solutions and build the integrated infrastructure needed to scale women's health nationwide—spanning maternal care, chronic pelvic conditions, midlife care, and outcomes-based reimbursement.
To view the complete speaker lineup and registration details, visit www.womenshealthx.com.
Herschel Ozturk-Walker
Women's HealthX
email us here
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
